Psychiatric disorders have been hypothesized to originate during development, with genetic and environmental factors interacting in the etiology of disease. Therefore, developmentally regulated genes have received attention as risk modulators in psychiatric diseases. Reelin is an extracellular protein essential for neuronal migration and maturation during development, and its expression levels are reduced in psychiatric disorders. Interestingly, several perinatal insults that increase the risk of behavioral deficits alter Reelin signaling. However, it is not known whether a dysfunction in Reelin signaling during perinatal stages increases the risk of psychiatric disorders. Here we used a floxed dab1 allele to study whether a transient decrease in Dab1, a key component of the Reelin pathway, is sufficient to induce behavioral deficits related to psychiatric disorders. We found that transient Dab1 downregulation during perinatal stages leads to permanent abnormalities of structural layering in the neocortex and hippocampus. In contrast, conditional inactivation of the dab1 gene in the adult brain does not result in additional layering abnormalities. Furthermore, perinatal Dab1 downregulation causes behavior impairments in adult mice, such as deficits in memory, maternal care, pre-pulse inhibition, and response to cocaine. Some of these deficits were also found to be present in adolescence. We also show that D-cycloserine rescues the cognitive deficits observed in floxed dab1 mice with layering alterations in the hippocampus and neocortex. Our results indicate a causal relation between the downregulation of Dab1 protein levels during development and the structural and behavioral deficits associated with psychiatric diseases in the adult.
INTRODUCTION
Dysregulation of key developmental processes, caused by environmental and/or genetic risk factors, is associated with the pathogenesis of neuropsychiatric diseases (Ansorge et al, 2007; Brown and Patterson, 2011; Krishnan and Nestler, 2008; Nestler and Hyman, 2010) . For example, maternal infection and early-life stress have been proposed as environmental risk factors for psychiatric disorders, although little is known about the mechanisms involved (Ansorge et al, 2007; Brown and Patterson, 2011; Krishnan and Nestler, 2008; Nestler and Hyman, 2010) . Nevertheless, developmental dysregulation of a few factors, such as Disc1 (Li et al, 2007) , NR1 in cortical interneurons (Belforte et al, 2009) , serotonin (Ansorge et al, 2008; Ansorge et al, 2004) , and dopamine (Kellendonk et al, 2006) , have been shown to cause dysfunctions related to these diseases.
Reelin, an extracellular protein essential for neuronal migration, has been shown to regulate glutamatergic neurotransmission in both developing and adult neurons (Pujadas et al, 2010; Tissir and Goffinet, 2003) . Reelin signals through ApoER2 and VLDLR receptors and leads to the phosphorylation of the adapter Dab1, which subsequently activates several pathways. The phenotypes of Dab1-and ApoER2/VLDLR-knockout mice are indistinguishable from Reelin-deficient mice, thereby indicating that these signaling components are essential for the Reelin pathway (Hiesberger et al, 1999; Howell et al, 1997b; Tissir and Goffinet, 2003) . Reelin expression is decreased in psychiatric disorders. In addition, reelin genetic variants are associated with these diseases, and Reelin overexpression protects against psychiatric disease-related phenotypes (Fatemi et al, 2000; Jia et al, 2010; Kim and Webster, 2009; Teixeira et al, 2011; Torrey et al, 2005) . Interestingly, perinatal insults that cause behavioral deficits in the adult, such as alcohol exposure during pregnancy, maternal viral infection or exposure to Poly I:C, and serotonin dysfunction, alter the Reelin signaling pathway (Fatemi et al, 1999; Hashimoto-Torii et al, 2011; Janusonis et al, 2004) . Thus, it has been proposed that the dysregulation of this pathway during development is crucial for psychiatricrelated deficits; however, this hypothesis has not been tested.
Mice homozygous for a floxed dab1 allele (flDab1) are hypomorphic for Dab1 protein at P1 (Pramatarova et al, 2008) . Here we used this animal model, in which the Dab1 expression is reduced only during perinatal stages, to test whether a transient reduction of the Reelin pathway is sufficient to cause the structural and behavioral dysfunctions related to psychiatric diseases. We show that Dab1 downregulation during perinatal stages leads to permanent layering alterations and to deficits in cognition and maternal care. In addition, these mice have increased cocaine response and deficient pre-pulse inhibition (PPI) after exposure to corticosterone, thus suggesting a geneenvironment interaction. Furthermore, we demonstrate that D-cycloserine rescues the cognitive deficits observed. These data suggest that that the downregulation of Dab1 during development is sufficient to cause both the structural and behavioral deficits related to psychiatric diseases.
MATERIALS AND METHODS

Animals
Floxed dab1 mice (Pramatarova et al, 2008) and Ubiquitous CreER T2 mice (Jackson Laboratories; B6.Cg-Tg(UBC-cre/ ESR1)1Ejb/J)) were maintained on a C57BL/6J background, and floxed Dab1 mice were backcrossed for five generations in our laboratory. Mutant mice and their littermate controls were housed in groups (two to six mice per cage) and maintained in a 12 h light/dark cycle with access to food and water ad libitum. Experiments were conducted blind and in compliance with local animal care protocols and European guidelines. We used three genotypes: dab1 wt/wt (WT), dab1 flox/flox (flDab1), and UbiCreER T2 /dab1 flox/flox (Cre/ flDab1). Mice were either injected with tamoxifen (TMX) (Cre/flDab1 þ TMX) or not (Cre/flDab1). Guided by a pilot study, we tested Cre/flDab1 þ TMX mice only when there were no differences between WT and flDab1 animals. All experiments were performed with male mice unless stated otherwise.
Tamoxifen Injection
In order to obtain temporally controlled, ubiquitous Cremediated recombination in Cre/flDab1 mice, we administered TMX infections (30 mg/ml in 1 : 10 alcohol:sunflower oil). Seven-week-old mice received daily intraperitoneal injections of 180 mg/kg for 3 days, at least 5 weeks before behavioral tests. In tests involving Cre/flDab1 animals, TMX was also injected in WT and flDab1 animals. Although we did not include Cre/flDab1 animals non-injected with TAM in all experiments, previous studies have shown that 4 weeks after TMX-treatment mice showed unaltered behaviors when compared with non-injected controls, except in the forced-swim-test (Vogt et al, 2008) .
Histology
After perfusion with 4% paraformaldehyde in PBS (N WT ¼ 9, N flDab1 ¼ 7, N Cre/flDab1 ¼ 4, N Cre/flDab1 þ TMX ¼ 9), brains were cryoprotected and sliced on a cryostat (50 mm thick). Sections were stained with Nissl dye and mounted in Eukitt (Panreac). The neuronal density in layer I (V1 and S1BF areas) and the thickness of the pyramidal layer in the CA1 region were measured (three to six mice per genotype, three sections/mice, and three replicates per section). The layering and thickness of neocortical areas were also analyzed. We also evaluated the degree of hippocampal atrophy across genotypes. The subiculum, CA1, and CA3 (subdivided into dorsal and ventral) regions of each animal were classified as 'normal', 'moderate', or 'severe' phenotype on the basis of the presence of specific morphological traits, exemplified in Supplementary Figure S3 . For immunohistochemistry, sections were immunoreacted with a Tbr1 antibody (1 : 1000; Abcam). After incubation with a secondary antibody and the ABC complex (Vectastain ABC kit; Vector Laboratories), sections were developed in a diaminobenzidine/nickel solution and mounted in Eukitt.
Western Blot
Brains from four mice per genotype were removed at several ages (E14, P1, P7, P14, and adult 4P60). The procedure used was as previously described (Pujadas et al, 2010) . Briefly, forebrains were lysed, and samples were resolved in SDS-polyacrylamide gels and transferred to nitrocellulose membranes. Blots were incubated in primary antibody diluted in TBST-5% non-fat milk for 2 h. After incubation with a secondary antibody for 1 h, membranes were developed with the ECL þ system (GE Healthcare). The following primary antibodies were used: sheep anti-mDab1 antibody (1 : 1000, Exalpha Biol.) and affinity-purified antibody anti-Dab1 (B3) (1 : 2000; (Howell et al, 1997a) ), mouse anti-Reelin (1 : 2000, Millipore), rabbit anti-ApoER2 (1 : 3000, ab 2561, Gift of J Herz), rabbit anti-VLDLR (1 : 3000, 2897, gift of J Herz), mouse anti-tubulin (1 : 100 000, Covance); and mouse anti-Actin (1 : 150 000, Chemicon).
RNA Purification and qRT-PCR Analysis
RNA from brain samples was obtained using Trizol (Invitrogen) as previously described (Pujadas et al, 2010) . RNA quality and concentration were determined by absorbance at 260 and 280 nm in a nanodrop (Agilent) and by analysis using a bioanalyzer (Agilent). Two nanograms of RNA per sample were reverse-transcribed and amplified using the RETROscript kit (Ambion). For gene expression assays, we used FAM dye-labeled TaqMan MGB probes specific for Dab1 (Mm00438366_m1), Reelin (Mm00465200_m1), and Actb (Mm00607939_s1). Reactions were developed in a 96-well plates in an ABI PRISM 7700 Sequence Detection System (Applied Biosystems). For quantification, we used three replicates per sample from four mice, per genotype, per age group. Differences in PCR efficiency were corrected, and data were analyzed using the Relative Expression Software Tool (REST-384) (Pfaffl et al, 2002) .
Corticosterone Treatment
Adult mice (two to three months of age) were given corticosterone (Sigma) in their drinking water (25 mg/l) for 3 weeks, as previously described (Gourley and Taylor, 2009; Teixeira et al, 2011) . Mice were tested 1 week after the end of treatment.
D-Cycloserine and Clozapine Injections
D-cycloserine (Sigma) was injected at a concentration of 20 mg/kg 20 min before behavioral tests. Clozapine (Sigma) was injected at a concentration of 0.63 mg/kg 30 min before behavioral tests.
Rota-Rod
On day one, mice were habituated to walking on the rota-rod for 1 min (Panlab) at 4 r.p.m. In the following 3 days, they were given two trials daily with the rotor-rod accelerating from 4 to 40 r.p.m. over 5 min. The average latency to fall was calculated for each mouse (
Social Recognition
The social recognition test was performed as described (Silverman et al, 2010) . Briefly, mice were allowed to explore an arena with three sections for 5 min. Next, a mouse inside a wire container was placed on one side of the arena and an empty wire container in the other section. Mice were allowed to explore these containers for 10 min. After this time, a novel mouse was placed in the empty container. The time the mice spent inspecting each of the containers was recorded for 10 min (N WT ¼ 6, N flDab1 ¼ 8, N Cre/flDab1 þ TMX ¼ 7).
Pup Retrieval
Poor maternal care is often seen in schizophrenic patients (Bosanac et al, 2003; Riordan et al, 1999; Wan et al, 2007) . To assess maternal care, we used the 'pup retrieval' test. In this test, the litter was removed from the nest at P7. Next, three pups were placed at the opposite side of the cage, and the time the mother took to retrieve all three pups and carry them back to the nest was measured. There was no significant difference between the number of pups in the litters of WT (6.9±0.4) and flDab1 (6.4±0.5) mothers. We performed this test with the pups that shared the same genotype as the mothers and all the pups heterozygous for the floxed Dab1 transgene for both genotypes of mothers (N WT/WT ¼ 9, N flDab1/flDab1 ¼ 6, N WT/Het ¼ 12, and N flDab1/ Het ¼ 17; represented as mother's genotype/pup's genotype).
Open Field (Anxiety)
The open field (OF) apparatus consisted of an open white arena measuring 43 Â 43 cm. Mice were allowed to walk freely over a 20-min trial. The time the mice spent in the center vs the time spent at the periphery of the arena (center: area 6 cm away from the walls), as well as the total distance traveled, were recorded (N WT ¼ 13, N flDab1 ¼ 12, N Cre/flDab1 þ TMX ¼ 8, and N Cre/flDab1 ¼ 15). 
Cocaine Sensitization
were habituated to the OF box for 2 days. Starting the following day, mice were either injected intraperitoneally with cocaine (7.5 mg/kg) or saline (Habituation group), and immediately placed in the OF box; this procedure was repeated for 5 consecutive days. Locomotion was recorded for 20 min using the Smart Junior software (Panlab).
Pre-Pulse Inhibition
The PPI apparatus and procedure were as previously described (Teixeira et al, 2011) . Mice were habituated to the apparatus with a background noise of 62 dB and then exposed to six blocks of eight trial types in pseudo-random order. The eight trial types were as follows: trial 1 (startle only), 40 ms of 120 dB background noise, 8000 Hz sound; trials 2-7 (pre-pulse trials), 40 ms of 120 dB, 8000 Hz sound preceded for 140 ms by a 20-ms pre-pulse sound of 70, 74, 78, 82, 86, or 90 dB; and trial 8, 62 dB (Untreated: 
Water Maze
The apparatus and procedure for training was as previously described (Teixeira et al, 2006) . Hidden version: guided by extra-maze visual cues, mice were trained to find a submerged platform placed in a fixed location of the pool. On each of the 6 (adults) or 4 (adolescent) training days, mice received six training trials (presented in two blocks of three trials). The order of the start locations was pseudo-randomly varied throughout training. The trial was complete once the mouse found the platform or when 60 s had elapsed. When the mouse failed to find the platform in a given trial, it was guided onto the platform. During the probe test, the platform was removed, and the search pattern of the mouse was recorded for 60 s.
Cued Water Maze
In this version of the water maze, mice were trained to find a platform marked with a local cue. Mice were given three trials a day for 4 days. Latency to find the platform was recorded (N WT ¼ 8, N flDab1 ¼ 14).
Statistical Analysis
Statistical differences were established using a two-tailed Student's t-test or ANOVA followed by an LSD or Bonferroni post hoc test. Data are expressed as mean±SEM.
RESULTS
Transient Downregulation of Dab1 Protein in flDab1 Mice
Mice homozygous for a flDab1 have been shown to be hypomorphic for Dab1 protein at P1. To analyze the time course of Dab1 expression in these mutants, we quantified Dab1 protein levels using western blots at several developmental stages (E14, P1, P7, P14, and adult; four mice/ genotype/time point). As shown in Figure 1a (and Supplementary Figure S1 ), flDab1 mice displayed lower levels of Dab1 than WT mice at P1 (t (6) ¼ 4.24, p ¼ 0.005) and P7 (t (6) ¼ 2.92, p ¼ 0.03) but expressed Dab1 at WT levels at E14 (t (6) ¼ 0.12, NS), P14 (t (6) ¼ 1.19, NS), and in the adult (t (6) ¼ À 1.72, NS). These results indicate that flDab1 mice experience a transient decrease in Dab1 protein during perinatal stages. Consistent with previous studies, Dab1 levels remained high in the adult brain.
To understand whether the Dab1 downregulation observed in flDab1 mice was due to differences at the RNA or protein level, we performed RT-PCR for dab1 at P1 and adult stages in WT and flDab1 animals (four mice/ genotype/time point) and analyzed the data using the REST software tool (Pfaffl et al, 2002) . Compared with WT animals, flDab1 mice showed lower dab1 expression by a factor of B6 at both P1 and adult stages (RESTr: po0.05), thereby indicating that flDab1 mice express lower Dab1 mRNA at both ages (see Discussion).
To test whether a further disruption of Dab1 in adulthood leads to deficits distinct from those in flDab1 animals (see below), we generated a conditional dab1 knockout mouse line by crossing flDab1 mice with a ubiquitous Cre line (UbiCreER
T2
) in which TMX-induced recombination leads to the inactivation of dab1 and the expression of betagalactosidase (Cre/flDab1 þ TMX; Figure 1b ). In these mice, Dab1 expression was dramatically reduced (Figure 1a ), whereas non-injected mice (Cre/flDab1) expressed Dab1 at levels comparable to those of flDab1 animals (Supplementary Figure S2) .
To study whether other components of the Reelin signaling cascade were also altered in flDab1 mice, we analyzed the expression of Reelin and the VLDLR and ApoER2 receptors. We found no differences in the expression of these proteins between genotypes at P1 (Figures 1e and f; ApoER2 t (6) ¼ 0.114, NS; VLDLR t (6) ¼ 0.4146, NS). Our western blots also confirmed that, although Reelin levels were higher at P1 than in adulthood in both genotypes (Figure 1d, F (1,12) ¼ 127.04, p ¼ 0.000), the opposite was true for Dab1 levels ( Figure 1c; F(1,8) ¼ 26.32, p ¼ 0.000). We thus conclude that flDab1 mice display a transient and specific reduction in Dab1 protein levels during perinatal stages.
flDab1 Mice Show Permanent Structural Abnormalities that are not Affected by Adult Inactivation of the dab1 Gene Next, we addressed whether transient Dab1 downregulation leads to structural deficits. Although adult flDab1 mice displayed a normal gross anatomy, Nissl-staining revealed ectopic pyramidal cells in the CA1 and CA3 regions of the hippocampus (Figures 2a and b) . Nissl-staining and Tbr1-immunolabeling showed no major alterations in the lamination of the neocortex. However, flDab1 mice showed a mild disorganization of layer II, which was particularly evident in the cingulate and retrosplenial cortices (Figures 2d, e, g and h) as well as in the entorhinal cortex (Figures 4a and b ) and piriform cortex (data not shown). Moreover, layer I in flDab1 mice appeared not to be as well-delineated as in WT littermate controls (Figures 2g and h; Figure 3e , f, i and j).
To determine whether such structural alterations were increased by the inactivation of the Dab1 gene in the adult, 8-week-old Cre/flDab1 mice were injected with TMX and their cortical cytoarchitectonics was examined 2 and 12 months later. The phenotype of these mice, regarding neocortical and hippocampal layering, appeared to be indistinguishable to that of flDab1 animals (Figures 2c, f and i; Figures 3c, d , g, h, k and l; Figure 4c ).
To further support these observations, we performed a quantitative analysis in the CA1 region and in the primary somatosensory (S1BF) and visual (V1) cortices ( Figures  3m-o) . The CA1 layering phenotype was similar in flDab1, Cre/flDab1, and Cre/flDab1 þ TMX mice (F (3,15) ¼ 36.87, po0.0001, post hoc po0.001). We also confirmed the presence of ectopic neurons in neocortical layer I in all three mutant genotypes, compared with control WT littermates, in either S1BF (F (3,15) ¼ 16.83, po0.0001, post hoc po0.01) or VI (F (3,13) ¼ 3.587 p ¼ 0.0437, post hoc po0.05). The overall layering of cortical areas S1BF and V1 was similar in all four genotypes (Figures 3p, q; S1BF Group: F (3,75) ¼ 0.16, NS; V1 Group: F (3,65) ¼ 0.40, NS).
We also performed a semiquantitative comparison of the structural deficits present at the ventral and dorsal hippocampal levels. We found that the abnormal layering phenotype was more conspicuous in the ventral than in the dorsal hippocampus (Supplementary Figure S3) . Finally, we were unable to find structural and layering alterations in the olfactory bulb, adult subventricular zone, or Islands of Calleja in flDab1 mice (Figures 4d-l) . This observation is consistent with fact that that these regions arise mainly during postnatal and adult stages.
Taken together, the present findings indicate that a transient downregulation of Dab1 protein during perinatal stages is sufficient to lead to permanent structural and layering alterations in the neocortex and hippocampus. Furthermore, we conclude that long-term inactivation of the dab1 gene in adult stages does not further influence neuronal layering.
flDab1 Mice Present Behavioral Phenotypes Related to Psychiatric Diseases
In order to understand the behavioral outcome of perinatal disruption of Dab1, we tested WT and flDab1 mice in an extensive array of tests to elucidate the positive and negative symptoms of schizophrenia as well as cognitive deficits. Guided by a pilot study, we included TMX-injected adult UbiCreER T2 /Dab1 flox/flox mice (Cre/flDab1 þ TMX) in the tests, in which we did not observe a difference between WT and flDab1 mice. First, in order to rule out possible motor deficits, the three groups of mice were tested on a rota-rod. No differences in performance were observed between groups (Figures 5a and b The negative symptoms of schizophrenia, including lack of motivation, social withdrawal, and diminished affective responsiveness, contribute to poor functional outcomes. In order to assess social behavior, we performed the social recognition test. Mice with problems in social recognition will spend less time exploring a 'new mouse' vs a mouse they had encountered before, whereas a general lack of social interest would reflect on a lack of preference for a container with a mouse inside vs an empty one. In this test, mice were first exposed to a three-chamber arena containing two empty wire cups. On the following day, the mice were again placed in this arena but a new mouse (Mouse 1) was placed inside one of the cups. All three groups spent significantly more time exploring the cup containing Mouse 1 than the empty container ( Figure 5c ; Cup: F (1,17) ¼ 26.21, p ¼ 0.000; post hoc p ¼ 0.000). On the third day, the mice were returned to the arena, but this time a new mouse (Mouse 2) was placed in the other wire cup. No differences in exploration behavior between genotypes were detected, with all three groups preferring the new mouse vs the one to which they were previously exposed (Figure 5d ; Novelty: F (1,18) ¼ 22.15, p ¼ 0.000; post hoc p ¼ 0.000).
To evaluate maternal care, we measured the time WT and flDab1 mothers took to retrieve three pups of their litter (Figure 5e ). First, we tested mothers with the same genotype as their litters; interestingly, flDab1 mothers took more time to retrieve and place their offspring back in the nest than WT animals (Figure 5e left; t (13) ¼ À 2.38, p ¼ 0.03). To rule out the possibility that the longer latency to retrieve the flDab1 babies was due to differences in pup behavior, we tested the mothers with heterozygous pups (Figure 5e right; t (27) ¼ À 2.33, p ¼ 0.03). Moreover, flDab1 mothers took longer to retrieve their litter than WT mothers. This finding suggests that flDab1 mothers are slower at retrieving pups, regardless of pup genotype and potential behavioral differences.
To further study the implication of Dab1 downregulation in anxiousness, we performed the OFT. Although WT and flDab1 animals spent a similar percentage of time in the center of the arena, suggesting similar levels of anxiety-like behavior, Cre/flDab1 þ TMX animals showed increased anxiety-like behavior, as indicated by less time spent in the center of the OFT arena (Figure 5f ). In contrast, Cre/ flDab1 animals that were not injected with TMX behaved in a similar manner to WT or flDab1 mice, (F (3,44) 
The novelty-induced hyperlocomotion test is often used to model positive symptoms of schizophrenia (van den Buuse, 2010). flDab1 and WT mice were placed in a novel OF environment for 20 min a day for 7 days. We observed no difference between these genotypes in the distance traveled in the OF over the 7 days, suggesting no difference in novelty-induced locomotion. However, Cre/flDab1 þ TMX maintained higher levels of locomotion during the 7 days of testing than WT and flDab1 mice. These higher locomotion levels were not observed in non-injected Cre/ flDab1 animals (Figures 6a and b ; Group: F (3,14) ¼ 3.87, p ¼ 0.03, post hoc p ¼ 0.03).
Positive symptoms of schizophrenia and manic behavior are also revealed by increased activity in response to psychostimulants (Geyer and Markou, 1995; Nestler and Hyman, 2010; Teixeira et al, 2011; van den Buuse, 2010) . WT and flDab1 showed similar levels of locomotion at baseline (Figures 6a and b) ; however, in response to cocaine administration, the latter displayed significantly higher locomotion than WT mice (Figures 6c and d Histograms showing average thickness of cortical layers in S1BF and V1 areas. or, stratum oriens; CA1, pyramidal layer; rad, stratum radiatum, slm, stratum lacunosum-moleculare; ml, molecular layers; DG, dentate gyrus; S1BF, primary somatosensory cortex, barrel field; V1, primary visual cortex; I-VI, cortical layers I-VI. Data are presented as mean ± SEM; *po0.05; **po0.01; ***po0.001; Bonferroni post hoc test. Scale bar ¼ 250 mm, pertains to all panels.
FlDab1 Mice Present PPI Deficits after Corticosterone Treatment
PPI deficits are common in patients with schizophrenia and are considered an endophenotype of the disorder. Under baseline conditions, we found no differences between WT, flDab1, and Cre/flDab1 þ TMX animals (Figures 6e  and f Figure S4) . The 'two-hit' model of psychiatric disease suggests that genetic alterations interact with environmental factors in the development of the disorder. One of the most salient environmental factors triggering psychiatric diseases is chronic stress (Krishnan and Nestler, 2008; Nestler and Hyman, 2010) . To model chronic stress in mice, we administered corticosterone over an extended period of time. Interestingly, corticosterone-treated flDab1 as well as Cre/flDab1 þ TMX mice presented reduced PPI as compared with corticosterone-treated WT mice (Figures 6g In the LEnt (a-c) layer II appears to be disrupted (arrowheads). Adult neurogenesis-related zones such as the OB (d-f), SVZ (g-i, arrows), and ICj (j-l, asterisks) present normal histological and layering patterns. LEnt, lateral entorhinal cortex; II-III-LD-IV, cortical layers II, II, lamina dissecans, IV; OB, olfactory bulb; GCL, granule cell layer; IPL, internal plexiform layer; Mi, mitral cell layer; EPL, external plexiform layer; GL, glomerular layer; SVZ, subventricular zone; LV, lateral ventricle; cc, corpus callosum; CPu, caudate putamen; ICj, island of Calleja. Scale bars ¼ 250 mm; scale bar in (a) refers to (a-c), in (d) refers to (d-f), in (g) refers to (g-i), and in j refers to (j-l). and h; Group: F (2,34) ¼ 7.16, p ¼ 0.003, post hoc po0.01), with no differences in startle amplitude (Supplementary Figure S4) . This finding points to a gene-environment interaction for the disruption of this behavior. Because cognitive deficits are common in schizophrenia and other psychiatric disorders (Arguello and Gogos, 2010) , we tested whether memory was affected. Although most studies in mice have focused on working memory, hippocampaldependent episodic memory is also affected in schizophrenic patients (Boyer et al, 2007) . Given the striking hippocampal morphological phenotype, we chose to model episodic memory using the Morris Water Maze task. First, to rule out possible interference in learning by non-mnemonic deficits, we tested the mice in the cued version of the water maze. No differences were detected between genotypes in this task (Figure 7a , Day Â Group: Next, we tested spatial memory in the water maze using a hidden platform in a fixed location of the pool. We trained mice for 6 days in the water maze and performed a probe test on day 7. flDab1 mice showed severe spatial memory deficits when compared with littermate controls, as indicated by the lower time spent in the target quadrant (where the platform was previously located) during the probe test (Figure 7b ). D-cycloserine, a partial agonist of the NMDA receptor, has been proposed as a potential therapeutic option in schizophrenia-associated memory deficits. As Reelin controls glutamatergic neurotransmission, we tested the capacity of D-cycloserine to rescue cognitive deficits in flDab1 mice. As shown in Figure 7b , D-cycloserine reverted the memory deficits observed in flDab1 mutant mice (Group Â Quadrant: F (6,54) ¼ 3.54, p ¼ 0.005, post hoc po0.001). Next, we tested the capacity of clozapine, an atypical antipsychotic drug, to improve memory in flDab1 mice. Clozapine, unlike D-cycloserine, was unable to enhance memory of these mice in the water 
Presence of Behavioral Deficits in Adolescent flDab1 Mice
We next tested whether the behavioral deficits observed in flDab1 mice were already present during adolescence. Twenty-one-day-old WT and flDab1 mice were trained in the water maze for 6 days. During the probe trial (Figure 8a ) WT mice spent significantly more time in the target quadrant than flDab1 mice (Quadrant Â Group Â Sex: F (3,69) ¼ 0.5, NS; Quadrant Â Group: F (3,69) ¼ 5.14, p ¼ 0.003, post hoc po0.05).
A separate group of 21-day-old WT and flDab1 mice underwent the cocaine sensitization protocol. As with adult injected animals, flDab1 mice injected with cocaine presented significantly higher locomotion than WT-injected mice (Figure 8b 
DISCUSSION
Our results demonstrate that the downregulation of Dab1 protein levels during perinatal stages has long-lasting structural and behavioral consequences. flDab1 mice, which exhibit transient downregulation of Dab1 at P1-P7, showed deficits in the water maze, maternal behavior, response to psychostimulants, and PPI after exposure to corticosterone. Moreover, although perinatal disruption of Dab1 signaling did not affect habituation to a new environment and anxietylike behavior in the OFT, further Dab1 inactivation during adulthood did. In addition, we show that the cognitive deficits in flDab1 mice can be rescued by D-cycloserine but not by clozapine. Finally, we show that some of the behavioral dysfunctions seen in the adult are already present during adolescence. Collectively, our results indicate that a reduction in Dab1 protein levels during development is sufficient to lead to the structural and behavioral deficits related to psychiatric diseases in the adult.
In the flDab1 hypomorphic model (Pramatarova et al, 2008) , we observed decreased Dab1 expression during perinatal stages. This decrease was transient (P1-P7 stages), with adult flDab1 mice displaying similar Dab1 protein levels to WT littermates. No expression changes were found in other components of the Reelin cascade, including Reelin and its receptors. This observation allowed us to study how a transient reduction of the Reelin signaling pathway during perinatal stages affects adult behavior and brain structure.
Regarding the mechanism of Dab1 downregulation during perinatal stages, it is well established that Reelin signaling through the adapter Dab1 leads to its tyrosine phosphorylation and subsequent ubiquitin-dependent degradation (Feng et al, 2007; Kerjan and Gleeson, 2007) . Consistent with such Reelin-dependent Dab1 degradation, Dab1 protein levels are higher in reeler Reelin-deficient mice and lower in Reelin overexpressing mice than in wild-type mice (Feng et al, 2007; Kerjan and Gleeson, 2007; Pujadas et al, 2010) . It is also well established that Reelin levels are higher during development and decrease dramatically in the adult brain (Howell et al, 1997a) . We thus propose that, although dab1 transcription in the adult flDab1 mouse is sufficient to maintain normal Dab1 levels as a result of the low level of Reelin signaling and consequent Dab1 degradation, at P1 in flDab1 mice, dab1 transcription is insufficient to keep Dab1 protein levels high because of the strong activation of the Reelin cascade and rapid degradation of Dab1 protein (Pramatarova et al, 2008) . Finally, our observation that inactivation of the dab1 gene in adult mice (Cre/flDab1 þ TMX line) does not lead to further layering abnormalities is consistent with the notion that the Reelin pathways is not required to maintain the cytoarchitectonics of the adult brain after the migratory period has been completed.
Environmental factors such as maternal infection and early-life stress are thought to contribute to the development of schizophrenia and depression (Brown and Patterson, 2011; Nestler and Hyman, 2010) . Interestingly, alcohol exposure in utero, serotonin dysfunction, and maternal infection have been shown to disrupt psychiatric disorder-related behaviors, in addition to reducing Reelin signaling (Fatemi et al, 1999; Hashimoto-Torii et al, 2011; Janusonis et al, 2004) . For example, maternal influenza infection reduces the number of Reelin-expressing cells in the offspring (Fatemi et al, 1999) , and Poly I:C administration during pregnancy leads to reduced Reelin levels and to behavioral phenotypes related to psychiatric disorders (Meyer et al, 2008) . In addition, several studies have reported an association between Reelin polymorphisms and psychiatric disorders, and Reelin levels have been shown to be reduced by 50% in these patients (Fatemi et al, 2000; Jia et al, 2010; Kim and Webster, 2009; Torrey et al, 2005) , thus further supporting the link between Reelin signaling and disease. Consistent with this, we found that Dab1 downregulation during the perinatal period leads to phenotypes related to psychiatric diseases that are exacerbated by factors associated with increased risk, such as stress and psychostimulants.
In addition to behavioral deficits, we observed cellular heterotopias in the cortex, which have also been described in the brains of subjects affected by psychiatric diseases, including schizophrenia and bipolar disorder (Connor et al, 2009 ). Interestingly, a recent report has shown that Disc1, a schizophrenia candidate protein, acts downstream of Dab1 to regulate cortical migration (Young-Pearse et al, 2010) . Genetic studies have implicated the disc1 gene in the development of psychiatric disorders (Jia et al, 2010; Kim and Webster, 2009) . Moreover, disruption of Disc1 function at P7 results in working memory deficits and reduced sociability, among other schizophrenia-related phenotypes (Li et al, 2007) . Altogether, these data point to the convergence of the Dab1 and Disc1 pathways for the wiring of the brain during development and thus for correct adult brain function. Interestingly, although both Disc1 and NMDA dysfunction have been implicated in the pathophysiology of schizophrenia independently, a recent report suggests that these two pathways are related (Ma et al, 2013) , with Disc1 deficiency leading to a decrease in D-serine (an endogenous agonist of the NMDA receptor) and subsequent behavioral dysfunction. This outcome may suggest a possible therapeutic function for D-cycloserine where the Dab1/Disc1 pathway may be disrupted, which is worthy of further investigation. The Reelin pathway regulates cortical development, synapse formation (Tissir and Goffinet, 2003) , and glutamatergic transmission (Herz and Chen, 2006) , all of which are dysregulated in several psychiatric disorders. In a previous study, we showed that Reelin overexpression prevents the development of psychiatric disease-related phenotypes (Teixeira et al, 2011 ). Here we demonstrate for the first time, to our knowledge, that Dab1 downregulation during perinatal stages is sufficient to trigger structural and behavioral deficits associated with psychiatric disorders. On the basis of our findings, we propose that Dab1 developmental dysregulation is an important risk factor for the pathogenesis of such disorders. In addition, we show that D-cycloserine rescues the cognitive deficits related to Dab1 dysregulation. This finding supports the potential of this drug as a therapeutic adjunct for the treatment of cognitive deficits in psychiatric disorders for which proper treatment is still unavailable.
